Introduction
Inflitza contains the active ingredient Midostaurin and is available under the brand name Inflitza. It is primarily used in the treatment of certain types of blood cancers, such as acute myeloid leukemia (AML) and mastocytosis.
Uses
Inflitza is prescribed to manage specific types of blood cancers, including AML and mastocytosis. It is typically used in combination with other medications as directed by a healthcare professional.
Dosage and Administration
The dosage and administration of Inflitza should be determined by a healthcare provider, as it may vary based on the specific condition being treated. Generally, it is taken orally with food to help reduce stomach upset. Follow the prescribed dosage and schedule diligently.
Mechanism of Action
Midostaurin, the active ingredient in Inflitza, works by inhibiting certain enzymes and proteins that are involved in the growth and survival of cancer cells. This action helps to slow down or stop the progression of the disease.
Side Effects
Common side effects of Inflitza may include nausea, vomiting, diarrhea, fatigue, and low blood cell counts. Serious side effects such as severe allergic reactions or prolonged bleeding should be reported to a healthcare professional immediately.
Drug Interactions
Inflitza may interact with certain medications, including strong CYP3A4 inhibitors, inducers, and substrates. Inform the prescribing healthcare provider about all medications, supplements, and herbal products being taken to avoid potential interactions.
Precautions
Patients using Inflitza should be cautious if they have liver or kidney problems, as dosage adjustments may be necessary. Additionally, avoid grapefruit and grapefruit juice while taking this medication, as they can affect its effectiveness.
Storage
Inflitza should be stored at room temperature, away from moisture and heat. It should be kept out of reach of children and pets.
Patient Tips
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Mastocytosis – Treatment (NHS UK) [Accessed 4 Jun. 2024] (online) Available at:
- Midostaurin (Drugs.com) [Accessed 2 Jun. 2024] (online) Available at:
- midostaurin capsule (RX) [Accessed 5 Jun. 2024] (online) Available at:
- Midostaurin (MedlinePlus) [Accessed 7 Jun. 2024] (online) Available at:
- [No authors listed] Midostaurin. 2023 Jul 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. [Accessed 18 Jun. 2024] Available at:
Reviews
There are no reviews yet.